Bio-Technology General Euflexxa 1% Sodium Hyaluronate

Negara: Singapura

Bahasa: Inggris

Sumber: HSA (Health Sciences Authority)

Tersedia dari:

FERRING PHARMACEUTICALS PRIVATE LIMITED

Kelas:

Class D medical device

Diproduksi oleh:

Bio-Technology General (Israel) Ltd.

Area terapi:

Orthopaedics

Indikasi Terapi:

EUFLEXXA is indicated for the treatment of pain caused by osteoarthritis of the knee, hip, temporomandibular, carpometacarpal, shoulder and ankle joints. EUFLEXXA aids in lubrication of the joint, allows for greater mobility and flexibility of the treated joint, and reduces pain in the affected joint.

Ringkasan produk:

Device System Info:[Sterile Medical Device], EUFLEXXA is packed in a single-use, aseptically-filled disposable sterile 2.25 ml syringe (nominal volume) containing either 1 ml or 2 ml of 1% microbial fermentation-derived NaHA in phosphate-buffered saline; Models: Euflexxa 1% Sodium Hyaluronate - 3 x 2ml, Euflexxa 1% Sodium Hyaluronate - 1 x 2ml

Tanggal Otorisasi:

2017-04-28